Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (141-150 of 243) with videos related to

Pageof 25
Sort By:
Molecular Therapy. Nucleic Acids|September 11, 2020
N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic ToolJoséphine Briand, Aurélien A Sérandour, Arulraj Nadaradjane, et al.
Cancer Letters|March 7, 2017
Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularizationZahia Benslimane-Ahmim, Jessica Pereira, Anna Lokajczyk, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysisSteven Georges, Julie Chesneau, Soizic Hervouet, et al.
Cytokine|March 10, 2012
Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral bedsMarie-Françoise Heymann, Fanny Herisson, Jean-Michel Davaine, et al.
Cytokine & Growth Factor Reviews|July 6, 2013
Osteoprotegerin: multiple partners for multiple functionsMarc Baud'huin, Laurence Duplomb, Stéphane Teletchea, et al.
Frontiers in Endocrinology|June 5, 2015
Oxytocin reverses osteoporosis in a sex-dependent mannerGuillaume E Beranger, Mansour Djedaini, Séverine Battaglia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survivalGaëlle Picarda, François Lamoureux, Loïc Geffroy, et al.
Journal of Biomedical Materials Research. Part A|June 3, 2016
Pro-osteoclastic in vitro effect of Polyethylene-like nanoparticles: Involvement in the pathogenesis of implant aseptic looseningKevin Brulefert, Luis A Córdova, Bénédicte Brulin, et al.
Frontiers in Cell and Developmental Biology|June 13, 2022
Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide TreatmentMarion Rabé, Lucie Fonteneau, Lisa Oliver, et al.
The American Journal of Pathology|September 18, 2012
Oncostatin M is a growth factor for Ewing sarcomaEmmanuelle David, Franck Tirode, Marc Baud'huin, et al.
Pageof 25

Showing results (141-150 of 243) with videos related to

Sort By:
Pageof 25
Molecular Therapy. Nucleic Acids|September 11, 2020
N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic ToolJoséphine Briand, Aurélien A Sérandour, Arulraj Nadaradjane, et al.
Cancer Letters|March 7, 2017
Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularizationZahia Benslimane-Ahmim, Jessica Pereira, Anna Lokajczyk, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysisSteven Georges, Julie Chesneau, Soizic Hervouet, et al.
Cytokine|March 10, 2012
Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral bedsMarie-Françoise Heymann, Fanny Herisson, Jean-Michel Davaine, et al.
Cytokine & Growth Factor Reviews|July 6, 2013
Osteoprotegerin: multiple partners for multiple functionsMarc Baud'huin, Laurence Duplomb, Stéphane Teletchea, et al.
Frontiers in Endocrinology|June 5, 2015
Oxytocin reverses osteoporosis in a sex-dependent mannerGuillaume E Beranger, Mansour Djedaini, Séverine Battaglia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survivalGaëlle Picarda, François Lamoureux, Loïc Geffroy, et al.
Journal of Biomedical Materials Research. Part A|June 3, 2016
Pro-osteoclastic in vitro effect of Polyethylene-like nanoparticles: Involvement in the pathogenesis of implant aseptic looseningKevin Brulefert, Luis A Córdova, Bénédicte Brulin, et al.
Frontiers in Cell and Developmental Biology|June 13, 2022
Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide TreatmentMarion Rabé, Lucie Fonteneau, Lisa Oliver, et al.
The American Journal of Pathology|September 18, 2012
Oncostatin M is a growth factor for Ewing sarcomaEmmanuelle David, Franck Tirode, Marc Baud'huin, et al.
Pageof 25